Atara Biotherapeutics Inc
NASDAQ: ATRA
$6.85
+$0.24 (+3.6%)
Real Time Data Delayed 15 Min.
ATRA Stock Chart and Intraday Price
ATRA Stock Data
| Asset Type | Common Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Address | 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO, CA, US |
| Fiscal Year End | December |
| Latest Quarter | 2023-12-31 |
| Market Cap | 81.66M USD |
| Shares Outstanding | 101,922,000 |
ATRA Articles
On Tuesday, Canaccord Genuity reiterated its rating on Atara Biotherapeutics and raised its wildly bullish target price even higher.
Published:
Atara Biotherapeutics finds itself caught between a rock and a hard place after Friday's drug study news concerning its treatment for multiple sclerosis.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.